For instance, in tauopathies, and in particular Alzheimer’s disease, ANXA2 may participate in amyloid protein degradation, cellular antioxidant defense, and anti-inflammatory processes. Here, ANXA2 is linked to early-onset autosomal dominant Alzheimer disease.